Cecal carcinoma: a different colon malignancy?

Area of Science:

• Oncology
• Gastroenterology
• Surgical Oncology

Background:

• Cecal carcinoma historically linked to poorer prognosis due to delayed symptom presentation.
• Early detection and treatment are crucial for improving outcomes in colorectal cancers.

Purpose of the Study:

• To evaluate clinical symptoms and clinicopathological staging in relation to survival for cecal carcinoma patients.
• To determine if cecal carcinoma prognosis differs significantly from other colon malignancies.

Main Methods:

• Retrospective analysis of 166 patients undergoing right hemicolectomy for cecal carcinoma.
• Utilized Cox regression model to assess the impact of symptoms (pain, anemia, palpable mass) and Dukes' staging on survival.
• Examined resected specimens for tumor stage and metastatic disease.

Main Results:

• Ninety percent of tumors were Dukes' B or C stage; only 5% showed widespread metastasis.
• Overall 5-year survival rate was 0.57.
• Anemia correlated with improved survival, particularly in Dukes' B stage patients, while pain and palpable mass showed no significant association.
• Dukes' staging demonstrated a strong correlation with survival outcomes.

Conclusions:

• Cecal carcinoma exhibits a similar prognostic profile to other colon malignancies.
• Anemia may serve as a prognostic indicator in specific stages of cecal carcinoma.
• Clinicopathological staging remains a critical factor in predicting survival for cecal carcinoma.